Type II Pediatric Supracondylar Humerus Fracture Management and Outcomes: A Prospective Multi-centre Cohort Study

NCT02963233 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2016-11-15

No results posted yet for this study

Summary

The treatment of pediatric supracondylar humerus fractures is controversial, but despite the injury's high incidence there is a lack of high level evidence to guide operative versus non-operative decision making for displaced fractures with an intact posterior cortex (Gartland Type II). This study aims to prospectively compare clinical, functional, and radiographic outcomes between operatively and non-operatively treated patients using a prospective multi-centre cohort design.

Conditions

Interventions

PROCEDURE

Closed reduction and percutaneous pinning and immobilization

PROCEDURE

Non-operative reduction and immobilization

Sponsors & Collaborators

  • Pediatric Orthopaedic Society of North America

    collaborator OTHER
  • British Columbia Children's Hospital

    lead OTHER

Eligibility

Min Age
2 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2018-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02963233 on ClinicalTrials.gov